Literature DB >> 30094932

Multiple bloodstream infections in pediatric stem cell transplant recipients: A case series.

Liron Grossmann1, Priscila Badia Alonso1, Adam Nelson1, Javier El-Bietar1, Kasiani C Myers1, Adam Lane1, Heidi Andersen2, David Haslam2, Sonata Jodele1, Stella M Davies1, Christopher E Dandoy1.   

Abstract

Bacterial bloodstream infections (BSIs) are associated with poor outcomes following stem cell transplantation (SCT). We describe the demographics, treatment, complications, and outcome of 23 pediatric SCT recipients who developed three or more BSIs in the first year after SCT at our center from 2011 through 2016. The majority underwent allogeneic SCT (n = 22/23;96%), mainly from an unrelated donor (n = 19/22,86%); developed grade 2-4 graft versus host disease (GVHD; n = 14/23, 61%), all steroid refractory; and were diagnosed with thrombotic microangiopathy (n = 21/23, 91%). One-year overall survival was 56% (n = 13/23). We observed a high rate of transplant-associated thrombotic microangiopathy and steroid-refractory acute GVHD in patients with three or more BSIs.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CLABSI; MBI-LCBI; bloodstream infections; pediatrics; stem cell transplant; thrombotic microangiopathy

Mesh:

Year:  2018        PMID: 30094932     DOI: 10.1002/pbc.27388

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  1 in total

1.  Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.

Authors:  Sonata Jodele; Christopher E Dandoy; Adam Lane; Benjamin L Laskin; Ashley Teusink-Cross; Kasiani C Myers; Gregory Wallace; Adam Nelson; Jack Bleesing; Ranjit S Chima; Russel Hirsch; Thomas D Ryan; Stefanie Benoit; Kana Mizuno; Mikako Warren; Stella M Davies
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.